Your search for "disease" return 101 results.
Ceva Swine Team conduct latest symposium >
Actinobacillus pleuropneumoniae: the latest scientific research applied to field control strategies.
Instituto Sanidad Ganadera, Argentina acquired by Ceva >
New company will build on strong biological expertise and expand Ceva’s platform in South American zone.
Joint Venture agreement between Ceva and Huadu signed in Beijing >
“Ceva Huadu” to become Innovation & R&D platform for biologicals
Parasiticides >
75% of all emerging human infectious diseases are of animal origin. Thanks to its products, Ceva fight against the spread of infectious disease that can be transmitted from wild or domestic animals an...
Ceva launches latest of its Vector Vaccines at VIV Asia 2011 >
VECTORMUNE HVT- NDV® generates strong interest at symposium organised to present new strategies to combat Newcastle Disease.
Ceva becomes official partner of Vet2011 >
2011 is World Veterinary year, let’s show pride in our profession “Vet for health, Vet for food, Vet for the planet!”.
Vector vaccines symposium - 23th September 2010 >
CEVA will hold its first vector vaccines symposium in San Diego, USA from october 6-8th2010. Together with presenting its advanced technology, the forum will encourage the sharing of worldwide experie...
Cardio-nephrology and hypertension >
In dogs…. Canine cardiology, a strategic area of expertise for Ceva, has benefited from substantial R&D investment. This investment has allowed the Group to develop, for the very first time in veter...
Business and scientific partnerships >
By fostering partnerships with universities, institutes, private and public research centres, Ceva is not only able to keep up with the latest advances in research, but also to expand and diversify sc...
Innovative Hatchery Vaccines >
For poultry producers, innovative hatchery vaccines allow uniform and consistent supply of healthy chicks, thanks to maximum protection and shedding control with no side effects.